Deals and Data

Deals and Data

Inovio Pharmaceuticals and GeneOne Life Science to test experimental Ebola vaccine in humans in the first half of 2015. (Reuters, 09/24/14)

UCSD named to $41.6 million program to find treatments for autoimmune diseases, including rheumatoid arthritis and lupus erythematosus. (U-T San Diego, 09/25/14)

Thermo Fisher Scientific, GlaxoSmithKline, and Pfizer collaborate to develop universal next-generation sequencing-based oncology test for solid tumors. (Genome Web, 09/25/14)

FDA approves Boehringer Ingelheim’s tiotropium bromide inhalation spray for maintenance treatment of broncospasm associated with COPD. (MedPage Today, 09/25/14)

Novartis’ secukinumab improves symptoms of psoriatic arthritis in two late-stage trials. (Reuters, 09/25/14)

Aethlon Medical and Boston University CTE Center collaborate to advance blood-based diagnostic test that could identify chronic traumatic encephalopathy in living individuals. (San Diego Business Journal, 09/26/14)

European Medicines Agency recommends Novartis’ Signifor LAR for treatment of rare hormonal disease, acromegaly. (Bidness ETC, 09/28/14)

Monsanto launches global center in Mexico for developing new hybrid and genetically modified strains of corn. (Reuters Africa, 09/29/14)

Takeda Pharmaceuticals & Seattle Genetics’ cancer drug was successful as consolidation therapy in late-stage trial for patients with a type of lymphatic cancer. (Reuters, 09/29/14)

GlaxoSmithKline launches $5 million Innovation Challenge Fund to advance open-access technology in the bioelectronics space. (MedCity News, 09/30/14)

Zogenix submits FDA application for new formulation of Zohydro, pain-killer, that is designed to be harder to abuse. (Fox Business, 10/01/14)

Illumina and AB Sciex launch OneOmics project to integrate proteomics and next-generation sequencing analysis. (Genome Web, 10/02/14)

With synthetic biology-based approach, J. Craig Venter Institute and Kansas State University find that bat influenza virus uncovered in 2009 poses little-to-no pandemic threat to humans. (Genome Web, 10/02/14)

GSK’s R&D division, Cellzome, develops thermal profiling-based method for identifying protein drug targets and measuring protein-drug binding. (Genome Web, 10/03/14)

Halozyme’s PEGPH20 for the treatment of pancreatic cancer earns orphan drug designation. (Healio, 10/03/14)

CareFusion to be acquired by Becton Dickinson in combination focused on medication systems for hospitals and pharmacies. (Fox Business, 10/05/14)

Novartis and BMS to test immuno-oncology drug Opdivo in combination with three experimental lung cancer drugs. (Yahoo, 10/06/14)

Merck Serono teams up with the Institute of Cancer Research and the Wellcome Trust, London to develop anticancer drugs, identify inhibtors of tankyrase, an enzyme of the ADP-ribose polymerase family. (GEN News, 10/07/14)

Regeneron’s Eylea injection indication expanded to include all forms of macular edema after retinal vein occlusion. (Medscape, 10/07/14)

AbbVie’s Humira gains approval for reducing signs and symptoms of moderately-to-severely active polyarticular juvenile idiopathic arthritis in patients aged ≥2 years. (Zacks, 10/07/14)

Sequenom purchases intellectual property from Isis Innovations covering noninvasive prenatal testing. (Genome Web, 10/07/14)

« Return to Table of Contents